Figure 2 Imaging of atherosclerotic plaque burden

Slides:

Advertisements

Similar presentations

Reversing Atherosclerosis with Aggressive Lipid Lowering Reversing Atherosclerosis with Aggressive Lipid Lowering Presented at American Heart Association.

Advertisements

Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.

ASTEROID A Study To evaluate the Effect of Rosuvastatin On Intravascular ultrasound- Derived coronary atheroma burden.

Lindsay and Choudhury, Nature Reviews: Drug Discovery 2008, 7: Imaging the vessel wall in atherosclerosis.

VBWG BRAVER Trial BRachial Artery Vascular Endothelium Reactivity Study A substudy of PROVE IT-TIMI 22.

Aortic and Carotid Magnetic Resonance Image (MRI) Imaging

Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prospective Application of Pre-Defined Intravascular.

Date of download: 5/30/2016 Copyright © The American College of Cardiology. All rights reserved. From: Coronary Computed Tomography Angiography as a Screening.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Dual Lipid-Lowering Strategy With Ezetimibe.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Year in Atherothrombosis J Am Coll Cardiol. 2012;60(10):

From: Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: Coronary artery disease regression.

Nat. Rev. Cardiol. doi: /nrcardio

Copyright © 2006 American Medical Association. All rights reserved.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Oxford Niacin Trial.

FATS- Familial Atherosclerosis Treatment Study

Figure 2 Response after initial increase in total tumour burden

Figure 10 Assessment of myocardial fibrosis

Figure 2 Different manifestations of myocardial ischaemia

Figure 4 Pharmacodynamic comparison of crushed versus integral

Figure 1 Cine cardiovascular magnetic resonance (CMR)

Figure 4 BMI and mortality in patients with heart failure

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Pathological specimens showing the most common reasons for bioprosthetic valve failure Figure 2 | Pathological specimens showing the most common.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 1 Anatomy of the femoral artery

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Management of acute coronary syndrome with intact fibrous cap

Figure 2 Three-year survival rates on the basis of body composition

Figure 3 3D printing of aortic and mitral valves

Figure 4 Imaging in patients with suspected acute coronary syndrome

Diagnosis of Atherosclerosis by Imaging

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.

Figure 10 Lipomatous hypertrophy of the atrial septum

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Ultrasound-guided femoral artery access

Figure 1 Health-care system today

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 4 Treatment plans using stereotactic body radiotherapy (SBRT)

Figure 4 TAVI for bicuspid aortic valve disease

Figure 2 Global cost of HF per capita in 2012

Figure 1 Manual thrombus aspiration

Nat. Rev. Cardiol. doi: /nrcardio

Figure 2 Apical hypertrophy missed by echocardiography

Nat. Rev. Cardiol. doi: /nrcardio

Figure 5 Bioresorbable vascular scaffold apposition and strut coverage

Nat. Rev. Cardiol. doi: /nrcardio

Figure 6 The neurogenic components of angina

Double-lumen carotid plaque: A morbid configuration

SMART-STRATEGY Trial design: Patients with a bifurcation coronary lesion were randomized to a conservative strategy (n = 128) vs. an aggressive strategy.

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Imaging of adverse plaque characteristics

Nat. Rev. Cardiol. doi: /nrcardio

Cardiovascular calcification in patients with chronic renal failure: Are we on target with this risk factor? Peter A. Mccullough, Sandeep Soman Kidney.

Alan Rozanski et al. JIMG 2017;10:

Baseline characteristics of study population

Figure 1 Imaging assessments of luminal stenosis, haemodynamic

Expression of CD40L and CD40 in human vascular atherosclerotic lesions in situ. Expression of CD40L and CD40 in human vascular atherosclerotic lesions.

Presentation transcript:

Figure 2 Imaging of atherosclerotic plaque burden Figure 2 | Imaging of atherosclerotic plaque burden. a | CT calcium scoring demonstrating macroscopic coronary calcification. b | Intravascular ultrasonography of coronary plaque demonstrating the outline of the vascular lumen (red) and plaque (orange). Cross-sectional magnetic resonance image of the same patient c | at baseline, and d | after 24 months of statin treatment, showing plaque regression at the level of the right carotid artery bifurcation. ICA, internal carotid artery; IJV, internal jugular vein. Panels c and d reprinted from Corti, R. et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 46 (1), 106–112 © (2005), with permission from Elsevier. Panels c and d reprinted from Corti, R. et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J. Am. Coll. Cardiol. 46 (1), 106–112 © (2005), with permission from Elsevier Dweck, M. R. et al. (2016) Imaging of coronary atherosclerosis — evolution towards new treatment strategies Nat. Rev. Cardiol. doi:10.1038/nrcardio.2016.79